Skip to main content

Homepage News

kidneyequipmentstock.jpg
Hero Type
Image
CWRU awarded $2.6M to study impact of high blood-pressure medications on chronic kidney disease patients
The National Institutes of Health awarded a four-year, $2.6 million grant to researchers at Case Western Reserve University to study how high blood-pressure drugs affect patients with chronic kidney disease (CKD). More specifically, they want to study whether such medications increase the risk of k...
leukemia%20blood%20cells%20stock.jpg
Hero Type
Image
Researchers awarded $1.3M to help military veterans battling acute myeloid leukemia
With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve University are investigating a new approach to treat acute myeloid leukemia (AML) in military veterans. AML is the most common form of blood cancer in adults, and many patien...
169genomestock.jpg
Hero Type
Image
CWRU awarded $1.9M federal grant to develop technology to better understand genome data
Research could lead to new discoveries in cancer medicine With a new five-year, $1.9 million grant from the National Institute of General Medical Sciences (NIGMS), researchers at Case Western Reserve University will develop computer software to analyze and interpret complex genome data. Analyzing ...
precision-surgery-feat.jpg
Hero Type
Image
Researchers at Case Western Reserve, Vanderbilt universities to develop incisionless prostate surgery using MRI and robotics
Researchers awarded five-year, $3.7M grant from National Institutes of Health, National Cancer Institute Researchers at Case Western Reserve University and Vanderbilt University are pioneering a new approach to prostate cancer surgery by combining advanced robotics and “low-field” MRI technology. ...
Researchers close in on understanding possible cause of Alzheimer’s disease
Awarded four-year, $3.3M grant from National Institutes of Health With a four-year, $3.3 million grant from the National Institutes of Health (NIH), researchers from Case Western Reserve University will study whether certain brain proteins may play a role in the development of Alzheimer’s disease. ...
169tinyinfantfootstock.jpg
Hero Type
Image
Research team launches first-of-its-kind study that could significantly impact clinical care for opioid-exposed infants at risk for developmental delays
With a $3 million grant from the NIH, experts are using advanced imaging technology to better understand changes in the infant brain that may accompany Neonatal Abstinence Syndrome Magnetic resonance fingerprinting (MRF), first described in the journal Nature in 2013 by engineers at Case Western Re...
169opioidstock.jpg
Hero Type
Image
Popular diabetes and weight-loss drug associated with lower opioid overdose risk
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics. New research from Case Western Reserve University School of Medicine identifies a potential new approach to...
Orientation Kicks Off 2024 Academic Year
The incoming class of MBA students enthusiastically kicked off the school year with a packed orientation schedule from August 15 to August 22. Approximately 200 students representing 21 countries were ushered into the new academic year with a robust agenda of activities and celebrations, beginning ...
IMG-990.jpg
Hero Type
Image
Entrepreneurship Through Acquisition Student Group: Building the future of entrepreneurship.
The 2024-2025 Weatherhead School of Management academic year marks a pivotal time for the Entrepreneurship Through Acquisition (ETA) student group. ETA is an alternative to startups for aspiring entrepreneurs, where the entrepreneur seeks the support of investors to find, acquire, operate, grow and...
stockrespiratorysystem.jpg
Hero Type
Image
CWRU team plays a key role in cystic fibrosis research
When it comes to diseases such as cystic fibrosis (CF), gene editing—a process that alters the biological properties of cells—can be fundamental in driving treatment. But as promising as it is in lab settings, effectively reaching patients’ lung cells with such treatments has been challenging. The ...